| Eumedica Pharmaceuticals AG - Temgesic 0,2 mg, Sublingualtabletten |
| 44100 | | 01 | | Temgesic 0,2 mg | | Sublingualtabletten | | N02AE01 | | Buprenorphine | | 01.03.1983 | | |
|
| Composition |
| buprenorphinum 0.2 mg ut buprenorphini hydrochloridum, lactosum monohydricum corresp. lactosum 28.349 mg, mannitolum, maydis amylum, povidonum K 30, acidum citricum, natrii citras dihydricus corresp. natrium 0.036 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Sublingualtabletten | | | | | Active Agent | Dose |
|---|
| Buprenorphinum | 0.2 mg |
| | BAG: Active Agent | Dose |
|---|
| Buprenorphinum | 0.2 mg |
| | | | Inactive agents | Dose |
|---|
| Acidum Citricum | | | Lactosum Monohydricum | | | | | | Mannitolum | | | | | | Natrii Citras Dihydricus | | | | 30 | | | |
| |
|
| Teilbarkeit |
| | Ja | | | | Nein | | | | Nein | | | | -- | | | | Nicht zerbeissen oder schlucken. Alternative: Temgesic Injektionslösung verwenden. | | | | | |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 010 | 10 Tablette(n) | 4.95 | 14.60 | A+ | SL | No | | 029 | 50 Tablette(n) | 21.78 | 40.10 | A+ | SL | No |
|
